TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Executive Column: Asa Ren pioneers genetic screening in Indonesia
Genetic analysis examines the building blocks of the human body to detect risks of disease long before any potential onset of symptoms. Asa Ren founder and CEO Aloysius Liang sees his company as a local pioneer in a field, whixh is expected to see rapid growth in the coming years.
Change Size
Asa Ren founder and CEO Aloysius Liang (Courtesy of Asa Ren/Courtesy of Asa Ren)
G
enetic analysis examines the building blocks of the human body to detect risks of disease long before any potential onset of symptoms. Asa Ren Pte Ltd considers itself a local pioneer in the field, which is expected to experience rapid growth in the coming years.
The global DNA sequencing market is expected to expand at a compound annual growth rate (CAGR) of 14.7 percent from US$11.06 billion in 2023 to 37.99 billion in 2032 according to a report by Precedence Research, which also predicts rapid growth in the Asia-Pacific region.
In an interview with The Jakarta Post's Yohana Belinda, Asa Ren founder and CEO Aloysius Liang discussed the future of genomic health care and how integrating genomics with artificial intelligence (AI) could enhance Indonesia’s health outcomes.
Driven by a personal experience of sickness in his family, Aloysius sees genomic health care as a way to improve diagnosis and treatment in the country.
How can individual DNA information help prevent disease or improve treatment in Indonesia?
First, you need data. During our grandparents' time, which saw the first wave of health care, they would use herbal medicines that were considered helpful. The second wave of health care was characterized by reactive treatment, with your parents bringing you to a doctor when you didn’t feel well. But now people realize […] a flaw in our medical system.
With the third wave, I think, […] we are moving to preventive health care, and this preventive health care requires big data.
